Clinical trial
A Study for Patients With Neurogenic Orthostatic Hypotension
NCT00046475 · Shire, Industry · Completed
Key facts
| NCT number | NCT00046475 |
|---|---|
| Title | A Study for Patients With Neurogenic Orthostatic Hypotension |
| Official title | A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Assess the Clinical Benefit of Midodrine Hydrochloride in Patients With Neurogenic Orthostatic Hypotension |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypotension, Orthostatic |
| Intervention type | Drug |
| Interventions | Midodrine Hydrochloride |
| Enrollment | 140 |
| Start date | Dec 1, 1997 |
| Primary completion | Nov 24, 1999 |
| Completion | Nov 24, 1999 |
| First posted | Oct 2, 2002 |
| Last update posted | Jun 11, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: